Vireo Growth (VREOF) Receivables - Net (2020 - 2026)
Vireo Growth (VREOF) posted Receivables - Net of $2.0 million for Q1 2026, down 84.25% sequentially from $12.7 million in Q4 2025, and down 17.51% YoY from $2.4 million in Q1 2025.
Vireo Growth (VREOF) Receivables - Net (2020 - 2026) Analysis & Trends
Vireo Growth has reported Receivables - Net for 7 years, with the latest figure at $2.0 million in Q1 2026.
- Quarterly Receivables - Net fell 17.51% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 17.51% YoY) and the FY2025 annual result came in at $12.7 million, up 342.48% from the prior year.
- Receivables - Net slipped to $2.0 million in Q1 2026 per VREOF's latest filing, from $12.7 million in the prior quarter.
- Over five years, Receivables - Net peaked at $12.7 million in Q4 2025 and troughed at $655217.0 in Q4 2023.
- A 5-year average of $3.4 million and a median of $2.1 million in 2023 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2022 and 2025: Receivables - Net soared 3243.59% in 2022, then sank 63.03% in 2025.
- Over 5 years, Receivables - Net stood at $1.4 million in 2022, then tumbled by 53.89% to $655217.0 in 2023, then soared by 135.88% to $1.5 million in 2024, then surged by 721.74% to $12.7 million in 2025, then sank by 84.25% to $2.0 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $2.0 million, $12.7 million, and $988641.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Vireo Growth | 491.44 Mn | 349.14 Mn | 95.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00 Mn |
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 12.70 Mn |
| Dec 31, 2025 | 12.70 Mn |
| Sep 30, 2025 | 988,641.00 |
| Sep 30, 2025 | 988,641.00 |
| Jun 30, 2025 | 9.14 Mn |
| Jun 30, 2025 | 9.14 Mn |
| Mar 31, 2025 | 2.42 Mn |
| Mar 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 2.26 Mn |
| Jun 30, 2024 | 2.26 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 655,217.00 |
| Dec 31, 2023 | 655,217.00 |